0378_AD_EEGWA_2_P
Analysis and correlation between the complete genome and brain activity for help in the diagnosis of Alzheimer's disease
1
Basisinformationen
-
Kurzbeschreibung des BeratungsunternehmensAlzheimer's disease (AD) is a serious public health problem, with a significant socioeconomic impact. The global cost associated with dementia reaches 154 billion euros per year, only in Western Europe. Early detection of AD, in its phase of mild cognitive impairment (MCI), is essential to optimize treatment. However, the diagnosis of MCI and AD requires a complex study. The fundamental objective of this project is to design a tool based on the analysis of the complete genome (through oral mucosa samples) and brain activity (using the electroencephalogram, EEG), which simplifies the current diagnostic protocols.
- geplanter Start des Projektes 01.10.2015 voraussichtliches Projektende 31.12.2019
- Dauer 50 (Monat (e))
Budget
- Gesamtbudget 543404 Projekt EU-Finanzierung 407553 Prozent: 75
Partner
DOKUMENTE
-
es sind derzeit keine Dokumente zu diesem Datensatz vorhanden